Skip to main content

Advertisement

Log in

A meta-analysis of combination therapy with gonadotrophin-releasing hormone agonist and growth hormone for children with idiopathic short stature and normal timed puberty

  • Meta-Analysis
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

The aim of this meta-analysis is to evaluate whether the combination therapy with gonadotrophin-releasing hormone agonist (GnRHa) and recombinant human growth hormone (rhGH) are effective in the treatment of children with idiopathic short stature (ISS) and normal timed puberty by interrogating data from clinical controlled trials.

Methods

Literature retrieval, trail selection, data abstraction and quality assessment were completed independently by two authors. STATA software (version 14.1) was used for data analyses.

Results

This meta-analysis was conducted based on 8 (4 randomized and 4 non-randomized) controlled trials. A total of 245 ISS children with normal timed puberty were financially analyzed. Overall, combination therapy with GnRHa and rhGH can slightly increase final height by 3.70 and 3.43 cm compared with GH treatment alone and no treatment, final height standard deviation score (FHSDS) by 0.10 and 0.22, final height minus predicted adult height (FH-PAH) by 1.5 and 5.32 cm, final height minus predicted adult height (FH-TH) by 7.70 and 4.32 cm, respectively. Subgroup and meta-regression analyses revealed that study type, sample size, GnRHa duration, and percentage of boys were potential sources of between-trial heterogeneity. There was a low probability of publication bias for above comparisons, as indicated by Egger’s tests.

Conclusions

Our meta-analytical findings indicate that the combination therapy with GnRHa and rhGH can slightly increase the final height of ISS children with normal timed puberty, and the effect was not more obvious than GH alone. We do not recommend the combination therapy as a routine treatment for ISS.

Trial registration number

CRD42019133438

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. S. Jafari-Adli, M. Qorbani, R. Heshmat, S.H. Ranjbar, E. Taheri, M.E. Motlagh, M. Noorozi, O. Safari, G. Shafiee, F. Rezaei, S. Safiri, R. Kelishadi, Association of short stature with life satisfaction and self-rated health in children and adolescents: the CASPIAN-IV study. J. Pediatr. Endocrinol. Metab. 29(11), 1299–1306 (2016). https://doi.org/10.1515/jpem-2016-0215

    Article  PubMed  Google Scholar 

  2. P. Cohen, A.D. Rogol, C.L. Deal, P. Saenger, E.O. Reiter, J.L. Ross, S.D. Chernausek, M.O. Savage, J.M. Wit, I.S.S.C.W. participants, Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J. Clin. Endocrinol. Metab. 93(11), 4210–4217 (2008). https://doi.org/10.1210/jc.2008-0509

    Article  CAS  PubMed  Google Scholar 

  3. J.M. Wit, P.E. Clayton, A.D. Rogol, M.O. Savage, P.H. Saenger, P. Cohen, Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm. IGF Res 18(2), 89–110 (2008). https://doi.org/10.1016/j.ghir.2007.11.004

    Article  CAS  PubMed  Google Scholar 

  4. A. Deodati, S. Cianfarani, Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review. BMJ 342, c7157 (2011). https://doi.org/10.1136/bmj.c7157

    Article  PubMed  Google Scholar 

  5. A.M. Ramos-Levi, M. Marazuela, Treatment of adult growth hormone deficiency with human recombinant growth hormone: an update on current evidence and critical review of advantages and pitfalls. Endocrine 60(2), 203–218 (2018). https://doi.org/10.1007/s12020-017-1492-1

    Article  CAS  PubMed  Google Scholar 

  6. E. Inzaghi, E. Reiter, S. Cianfarani, The challenge of defining and investigating the causes of idiopathic short stature and finding an effective therapy. Horm. Res. Paediatr. 92(2), 71–83 (2019). https://doi.org/10.1159/000502901

    Article  CAS  PubMed  Google Scholar 

  7. A. Deodati, E. Peschiaroli, S. Cianfarani, Review of growth hormone randomized controlled trials in children with idiopathic short stature. Horm. Res. Paediatr. 76(Suppl 3), 40–42 (2011). https://doi.org/10.1159/000330157

    Article  CAS  PubMed  Google Scholar 

  8. J. Bryant, L. Baxter, C.B. Cave, R. Milne, Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst. Rev. 3, CD004440 (2007). https://doi.org/10.1002/14651858.CD004440.pub2

    Article  Google Scholar 

  9. J.F. Sotos, N.J. Tokar, Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit. Int. J. Pediatr. Endocrinol. 2014(1), 15 (2014). https://doi.org/10.1186/1687-9856-2014-15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. V.L. Chulani, L.P. Gordon, Adolescent growth and development. Prim. Care 41(3), 465 (2014). 10.1016/j.pop.2014.05.002–487

    Article  Google Scholar 

  11. J.C. Carel, E.A. Eugster, A. Rogol, L. Ghizzoni, M.R. Palmert, E.-L.G.A.C.C. Group, F. Antoniazzi, S. Berenbaum, J.P. Bourguignon, G.P. Chrousos, J. Coste, S. Deal, L. de Vries, C. Foster, S. Heger, J. Holland, K. Jahnukainen, A. Juul, P. Kaplowitz, N. Lahlou, M.M. Lee, P. Lee, D.P. Merke, E.K. Neely, W. Oostdijk, M. Phillip, R.L. Rosenfield, D. Shulman, D. Styne, M. Tauber, J.M. Wit, Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123(4), e752–e762 (2009). https://doi.org/10.1542/peds.2008-1783

    Article  PubMed  Google Scholar 

  12. K.C.J. Yuen, S. Llahana, B.S. Miller, Adult growth hormone deficiency: clinical advances and approaches to improve adherence. Expert Rev. Endocrinol. Metab. 14(6), 419–436 (2019). https://doi.org/10.1080/17446651.2019.1689119

    Article  CAS  PubMed  Google Scholar 

  13. J.C. Carel, Management of short stature with GnRH agonist and co-treatment with growth hormone: a controversial issue. Mol. Cell. Endocrinol. 254–255, 226–233 (2006). https://doi.org/10.1016/j.mce.2006.04.034

    Article  CAS  PubMed  Google Scholar 

  14. J. Carel, Can we increase adolescent growth? Eur. J. Endocrinol. 151(Suppl 3), U101-8 (2004). https://doi.org/10.1530/eje.0.151u101

    Article  PubMed  Google Scholar 

  15. G. Saggese, G. Cesaretti, S. Barsanti, A. Rossi, Combination treatment with growth hormone and gonadotropin-releasing hormone analogs in short normal girls. J. Pediatr. 126(3), 468–473 (1995)

    Article  CAS  Google Scholar 

  16. A.M. Pasquino, I. Pucarelli, M. Roggini, M. Segni, Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone. J. Clin. Endocrinol. Metab. 85(2), 619–622 (2000). https://doi.org/10.1210/jcem.85.2.6387

    Article  CAS  PubMed  Google Scholar 

  17. J.A. Yanovski, S.R. Rose, G. Municchi, O.H. Pescovitz, S.C. Hill, F.G. Cassorla, G.B. Cutler Jr, Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N. Engl. J. Med. 348(10), 908–917 (2003). https://doi.org/10.1056/NEJMoa013555

    Article  CAS  PubMed  Google Scholar 

  18. L. Dunkel, Treatment of idiopathic short stature: effects of gonadotropin-releasing hormone analogs, aromatase inhibitors and anabolic steroids. Horm. Res. Paediatr. 76(Suppl 3), 27–29 (2011). https://doi.org/10.1159/000330150

    Article  CAS  PubMed  Google Scholar 

  19. R. Balducci, V. Toscano, A. Mangiantini, G. Municchi, F. Vaccaro, S. Picone, A. Di Rito, B. Boscherini, Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone. J. Clin. Endocrinol. Metab. 80(12), 3596–3600 (1995). https://doi.org/10.1210/jcem.80.12.8530605

    Article  CAS  PubMed  Google Scholar 

  20. D. Lindner, J.C. Job, J.L. Chaussain, Failure to improve height prediction in short-stature pubertal adolescents by inhibiting puberty with luteinizing hormone-releasing hormone analogue. Eur. J. Pediatr. 152(5), 393–396 (1993)

    Article  CAS  Google Scholar 

  21. J.C. Carel, F. Hay, R. Coutant, D. Rodrigue, J.L. Chaussain, Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development. J. Clin. Endocrinol. Metab. 81(9), 3318–3322 (1996). https://doi.org/10.1210/jcem.81.9.8784090

    Article  CAS  PubMed  Google Scholar 

  22. C. Bouvattier, J. Coste, D. Rodrigue, C. Teinturier, J.C. Carel, J.L. Chaussain, P.F. Bougneres, Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J. Clin. Endocrinol. Metab. 84(10), 3575–3578 (1999). https://doi.org/10.1210/jcem.84.10.6032

    Article  CAS  PubMed  Google Scholar 

  23. R. Lanes, P. Gunczler, Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty. Clin. Endocrinol. 49(2), 197–202 (1998)

    Article  CAS  Google Scholar 

  24. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, P. Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, b2535 (2009). https://doi.org/10.1136/bmj.b2535

    Article  PubMed  PubMed Central  Google Scholar 

  25. J.P. Frindik, J. Baptista, Adult height in growth hormone deficiency: historical perspective and examples from the national cooperative growth study. Pediatrics 104(4 Pt 2), 1000–1004 (1999)

    Article  CAS  Google Scholar 

  26. O. Ghai, V. Paul, A. Bagga. Essential Pediatrics. 7th ed. (CBS Publishers and Distributors Pvt. Limited, India, 2010)

    Google Scholar 

  27. M.B. Ranke, Towards a consensus on the definition of idiopathic short stature. Horm. Res. 45(Suppl 2), 64–66 (1996). https://doi.org/10.1159/000184851

    Article  CAS  PubMed  Google Scholar 

  28. W.A. Marshall, J.M. Tanner, Variations in the pattern of pubertal changes in boys. Arch. Dis. Child. 45(239), 13–23 (1970). https://doi.org/10.1136/adc.45.239.13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. W.A. Marshall, J.M. Tanner, Variations in pattern of pubertal changes in girls. Arch. Dis. Child. 44(235), 291–303 (1969). https://doi.org/10.1136/adc.44.235.291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. M. Crowther, W. Lim, M.A. Crowther, Systematic review and meta-analysis methodology. Blood 116(17), 3140–3146 (2010). https://doi.org/10.1182/blood-2010-05-280883

    Article  CAS  PubMed  Google Scholar 

  31. K. Slim, E. Nini, D. Forestier, F. Kwiatkowski, Y. Panis, J. Chipponi, Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J. Surg. 73(9), 712–716 (2003)

    Article  Google Scholar 

  32. R. DerSimonian, R. Kacker, Random-effects model for meta-analysis of clinical trials: an update. Contemp. Clin. Trials 28(2), 105–114 (2007). https://doi.org/10.1016/j.cct.2006.04.004

    Article  PubMed  Google Scholar 

  33. J. Bowden, J.F. Tierney, A.J. Copas, S. Burdett, Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med. Res. Methodol. 11, 41 (2011). https://doi.org/10.1186/1471-2288-11-41

    Article  PubMed  PubMed Central  Google Scholar 

  34. I. Benabbad, M. Rosilio, M. Tauber, E. Paris, A. Paulsen, L. Berggren, H. Patel, J.C. Carel, Phoenix Study, G., Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature. Endocr. Connect. 7(5), 708–718 (2018). https://doi.org/10.1530/EC-18-0137

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. S.A. van Gool, G.A. Kamp, H. Visser-van Balen, D. Mul, J.J. Waelkens, M. Jansen, L. Verhoeven-Wind, H.A. Delemarre-van de Waal, S.M. de Muinck Keizer-Schrama, G. Leusink, J.C. Roos, J.M. Wit, Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty. J. Clin. Endocrinol. Metab. 92(4), 1402–1408 (2007). https://doi.org/10.1210/jc.2006-2272

    Article  CAS  PubMed  Google Scholar 

  36. G.A. Kamp, D. Mul, J.J. Waelkens, M. Jansen, H.A. Delemarre-van de Waal, L. Verhoeven-Wind, M. Frolich, W. Oostdijk, J.M. Wit, A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J. Clin. Endocrinol. Metab. 86(7), 2969–2975 (2001). https://doi.org/10.1210/jcem.86.7.7650

    Article  CAS  PubMed  Google Scholar 

  37. J.C. Job, J.E. Toublanc, F. Landier, Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist. Horm. Res. 41(5-6), 177–184 (1994). https://doi.org/10.1159/000183889

    Article  CAS  PubMed  Google Scholar 

  38. M.A. Magiakou, D. Manousaki, M. Papadaki, D. Hadjidakis, G. Levidou, M. Vakaki, A. Papaefstathiou, N. Lalioti, C. Kanaka-Gantenbein, G. Piaditis, G.P. Chrousos, C. Dacou-Voutetakis, The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J. Clin. Endocrinol. Metab. 95(1), 109–117 (2010). https://doi.org/10.1210/jc.2009-0793

    Article  CAS  PubMed  Google Scholar 

  39. K.O. Klein, P.A. Lee, Gonadotropin-releasing hormone (GnRHa) therapy for central precocious puberty (CPP): review of nuances in assessment of height, hormonal suppression, psychosocial issues, and weight gain, with patient examples. Pediatr. Endocrinol. Rev. 15(4), 298–312 (2018). https://doi.org/10.17458/per.vol15.2018.kl.GnRHaforCPP

    Article  PubMed  Google Scholar 

  40. R.H. Willemsen, D. Elleri, R.M. Williams, K.K. Ong, D.B. Dunger, Pros and cons of GnRHa treatment for early puberty in girls. Nat. Rev. Endocrinol. 10(6), 352–363 (2014). https://doi.org/10.1038/nrendo.2014.40

    Article  CAS  PubMed  Google Scholar 

  41. S. Li, X. Wang, Y. Zhao, W. Ji, J. Mao, M. Nie, X. Wu, Combined therapy with GnRH analogue and growth hormone increases adult height in children with short stature and normal pubertal onset. Endocrine 69(3), 615–624 (2020). https://doi.org/10.1007/s12020-020-02375-5

    Article  CAS  PubMed  Google Scholar 

  42. N. Khawaja, H. Owaineh, A. Batieha, O. Frahid, M. El-Khateeb, K.M. Ajlouni, The effect of gonadotropin-releasing hormone analogue on final adult height in children with idiopathic short stature. Med. Princ. Pract. 28(6), 509–516 (2019). https://doi.org/10.1159/000499929

    Article  PubMed  PubMed Central  Google Scholar 

  43. H. Visser-van Balen, R. Geenen, J. Looij, J. Huisman, J.M. Wit, G. Sinnema, The views of young adults and their parents on hormone treatment for short stature in adolescence. Horm. Res. 69(3), 172–179 (2008). https://doi.org/10.1159/000112591

    Article  CAS  PubMed  Google Scholar 

  44. H. Visser-van Balen, R. Geenen, G.A. Kamp, J. Huisman, J.M. Wit, G. Sinnema, Long-term psychosocial consequences of hormone treatment for short stature. Acta Paediatr. 96(5), 715–719 (2007). https://doi.org/10.1111/j.1651-2227.2007.00235.x

    Article  PubMed  Google Scholar 

  45. M.R. Munafo, J. Flint, Meta-analysis of genetic association studies. Trends Genet 20(9), 439–444 (2004). https://doi.org/10.1016/j.tig.2004.06.014

    Article  CAS  PubMed  Google Scholar 

Download references

Author contributions

Conceived and designed the article: L.W., Z.Z., W.N. Performed the experiments: B.Z., S.L., W.N. Analyzed the data: B.Z., S.L., Y.Y. Contributed materials/analysis tools: B.Z., J.W., Z.Z. Wrote and revised the paper: B.Z., T.Z., W.N., L.W. All authors read and approved the final manuscript prior to submission.

Funding

This research was supported by Public Service Development and Reform Pilot Project, Beijing Municipal Health Commission (BMR2019-11), Capital’s Funds for Health Improvement and Research (2020-2-2104), and Research Foundation of Capital Institute of Pediatrics (CXYJ-2021-08, QN-2020-09).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Wenquan Niu, Zhixin Zhang or Lin Wang.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, B., Liu, S., Wang, J. et al. A meta-analysis of combination therapy with gonadotrophin-releasing hormone agonist and growth hormone for children with idiopathic short stature and normal timed puberty. Endocrine 75, 698–708 (2022). https://doi.org/10.1007/s12020-021-02970-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-021-02970-0

Keywords

Navigation